Recruiting
Early Phase 1

ONT01 with Mycophenolate Mofetil

Sponsor:

Hospital for Special Surgery, New York

Code:

NCT07107659

Conditions

Lupus Nephritis (LN)

Lupus Nephritis - WHO Class III

Lupus Nephritis - WHO Class IV

Lupus Nephritis - World Health Organization (WHO) Class III

Lupus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ONT01 is a small molecule CD11b modulator.

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-14. This information was provided to ClinicalTrials.gov by Hospital for Special Surgery, New York on 2025-11-20.